Mechoulam on the Next 50 Years

Mechoulam on the Next 50 Years

Dr. Mechoulam speaks on "Planning Research for the Next Half a Century" at the 2012 International Cannabinoid Research Society (ICRS) meeting in Freiburg, Germany.
Dr. Mechoulam speaks on "Planning Research for the Next Half a Century" at the 2012 International Cannabinoid Research Society (ICRS) meeting in Freiburg, Germany.
Raphael Mechoulam on the future of cannabinoid science at ICRS

Raphael Mechoulam, professor of Medicinal Chemistry and Natural Products at the Hebrew University of Jerusalem, began “reading on cannabis and planning some limited amount of work on it” in 1962. The work turned out to be limitless. Over the course of 50 years Mechoulam has participated in a remarkable number of cannabis-related achievements. He and his colleagues isolated and elucidated the chemical structure of THC, CBD, and many other plant cannabinoids (a term Mechoulam himself coined). They did the same for the endogenous cannabinoids, anandamide and 2-AG. They figured out the steps by which these compounds are synthesized in the body and exert their effects by activating receptors. Their accomplishments have dramatically advanced cannabinoid sciences. Learn what may be next in cannabis research.

Revision date: 
Feb 23, 2014

Find CBD near you

Browse hundreds of retail locations for quality CBD products.

Search

News & Reports

Climate change and cannabis commerce point to a green future

Top Conditions

In compiling a list of conditions that CBD may help, we examined hundreds of peer-reviewed articles in scientific journals.

Cannabis Conversations

Project CBD talks with Dr. Bonni Goldstein about whole plant cannabis remedies, nonintoxicating cannabinoids, and cancer care for children.
Expert cannabis botanist and geneticist Ryan Lee talks to Project CBD about breeding cannabis, THC & CBD content, and how to interpret lab data.
Project CBD speaks with Dr. Rachel Knox about "endocannabinology," THC/CBD synergies, and whole food nutrition.

Thanks to our sponsors and supporters:

Top Stories